Impact of the number of positive lymph nodes on disease-free survival in patients with pathological stage B1 nonseminomatous germ cell tumor

Journal of Urology

Volumn 174, Issue 1, 2005, Pages 143-145

  Beck, Stephen D W ^a   Foster, Richard S ^a   Bihrle, Richard ^a   Cheng, Liang ^a   Ulbright, Thomas M ^a   Donohue, John P ^a  

^a INDIANA UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

Lymph nodes; Prognosis; Testicular neoplasms; Testis

Indexed keywords

ANTINEOPLASTIC AGENT;

ARTICLE; BLADDER CANCER; CANCER ADJUVANT THERAPY; CANCER RECURRENCE; CANCER SURVIVAL; CONTROLLED STUDY; FOLLOW UP; GERM CELL TUMOR; HUMAN; LYMPH NODE DISSECTION; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; NON SEMINOMATOUS GERMINOMA; PATHOLOGY; PRIORITY JOURNAL; PROGNOSIS; TREATMENT OUTCOME;

EID: 20444504270     PISSN: 00225347     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.ju.0000161603.65138.90     Document Type: Article

References (11)

1. Fisher, B., Bauer, M., Wickerham, D. L., Redmond, C. K., Fisher, E. R., Cruz, A. B. et al: Relation of number of positive axillary nodes to the prognosis of patients with primary breast cancer. An NSABP update. Cancer, 52: 1551, 1983
2. Williams, S. T. and Beart, R. W., Jr.: Staging of colorectal cancer. Semin Surg Oncol, 8: 89, 1992
3. Herr, H. W.: Superiority of ratio based lymph node staging for bladder cancer. J Urol, 169: 943, 2003
4. Mills, R. D., Turner, W. H., Fleischmann, A., Markwalder, R., Thalmann, G. N. and Studer, U. E.: Pelvic lymph node metastases from bladder cancer: outcome in 83 patients after radical cystectomy and pelvic lymphadenectomy. J Urol, 166: 19, 2001
5. Stein, J. P., Cai, J., Groshen, S. and Skinner, D. G.: Risk factors for patients with pelvic lymph node metastases following radical cystectomy with en bloc pelvic lymphadenectomy: the concept of lymph node density. J Urol, 170: 35, 2003
6. Herr, H. W., Bochner, B. H., Dalbagni, G., Donat, S. M., Reuter, V. E. and Bajorin, D. F.: Impact of the number of lymph nodes retrieved on outcome in patients with muscle invasive bladder cancer. J Urol, 167: 1295, 2002
7. Rabbani, F., Sheinfeld, J., Farivar-Mohseni, H., Leon, A., Rentzepis, M. J., Reuter, V. E. et al: Low-volume nodal metastases detected at retroperitoneal lymphadenectomy for testicular cancer: pattern and prognostic factors for relapse. J Clin Oncol, 19: 2020, 2001
8. Richie, J. P. and Kantoff, P. W.: Is adjuvant chemotherapy necessary for patients with stage B1 testicular cancer? J Clin Oncol, 9: 1393, 1991
9. Fleming, I. D., Cooper, J. S., Henson, D. E., Hutter, R. V. P., Kennedy, B. J., Murphy, G. P. et al: AJCC Cancer Staging Manual, 5th ed. Philadelphia: Lippincott-Raven, 1997
10. Pizzocaro, G. and Monfardini, S.: No adjuvant chemotherapy in selected patients with pathologic stage II nonseminomatous germ cell tumors of the testis. J Urol, 131: 677, 1984
11. Williams, S. D., Stablein, D. M., Einhorn, L. H., Muggia, F. M., Weiss, R. B., Donohue, J. P. et al: Immediate adjuvant chemotherapy versus observation with treatment at relapse in pathological stage II testicular cancer. N Engl J Med, 317: 1433, 1987